SBC Medical Group Holdings Announces First Quarter 2026 Financial Results
Irvine, Calif.–(ANTARA/Business Wire)– SBC Medical Group Holdings Incorporated (Nasdaq: SBC) (“SBC Medical” or “the Company”) is a medical service company that provides management support in various fields of healthcare. Today, SBC Medical announced its financial results for the three months ended March 31, 2026.
First Quarter 2026 Highlights
Total revenue was $43 million, a decrease of 9% year-over-year.
Net income attributable to SBC Medical Group Holdings Incorporated was $11 million, a decrease of 47% year-over-year. Net profit margin was 26% in the first quarter of 2026, a decrease of 19 percentage points year-over-year.
Earnings per share, defined as net income attributable to the Company divided by the weighted average number of shares outstanding, was $0.11 for the three months ended March 31, 2026, a decrease of 48% year-over-year.
EBITDA1, calculated by adding depreciation and amortization expense to operating income, was $18 million, a decrease of 26% year-over-year. EBITDA1 margin was 43% for the first quarter of 2026, a decrease of 10 percentage points year-over-year.
Return on equity2, which is net income attributable to the Company divided by the average shareholders’ equity as of March 31, 2026, was 18%, a decrease of 23 percentage points year-over-year.
The number of franchise locations3 was 284 as of March 31, 2026, an increase of 33 locations from March 31, 2025.
The number of customers4 in the last twelve months ended March 31, 2026, was 6.76 million, an increase of 10% year-over-year.
The customer retention rate5, which is the percentage of customers who visited franchise clinics at least twice, was 72%.
Yoshiyuki Aikawa, Chairman and CEO of SBC Medical, said, “For the first quarter of fiscal year 2026, SBC Medical reported revenue of $43 million, a decrease of 9% year-over-year. This decrease was primarily due to the strategic restructuring implemented in April 2025, which involved revising the franchise cost structure. Apart from this structural change, our core business performance remains strong. In terms of profitability, our net profit margin reached 26% and our EBITDA margin remained high at 43%.
Going forward, we will continue to promote our multi-brand strategy in the field of aesthetic dermatology, expand our non-aesthetic medical business, and strengthen our operational base in overseas markets. In addition, we will pursue opportunities in the longevity market and further enhance our services by leveraging AI to build a sustainable and continuously evolving healthcare platform.”
Conference Call
The Company will hold a conference call on Thursday, May 14, 2026, at 8:30 a.m. Eastern Time (or Thursday, May 14, 2026, at 9:30 p.m. Japan Time) to discuss the first quarter financial results ended March 31, 2026. A question-and-answer session with analysts and investors will be held after the prepared remarks.
Please register for the conference in advance using the link below: https://zoom.us/webinar/register/WN_6RZgrwsUREiRpAmBBGTikA
This link will automatically direct you to the registration page for the “First Quarter 2026 Earnings Conference Call.” Please follow all the steps to enter the registration details, and then click “Submit.” After registering, you can access the dedicated website to join the Conference Call. In addition to viewing the conference call, this website also contains information about the speakers and previous investor relations materials.
In addition, the earnings release, supporting slides, and archived webcast of the conference call will be available on the Company’s Investor Relations website at https://ir.sbc-holdings.com/
About SBC Medical
SBC Medical Group Holdings Incorporated is a medical service company that provides management support in various fields of healthcare, including advanced aesthetic medicine, dermatology, orthopedics, fertility treatment, gynecology, dentistry, alopecia (AGA) treatment, and ophthalmology. The Company manages a diverse portfolio of clinic brands and is actively expanding its global presence, particularly in the United States and Asia, through direct operations and medical tourism initiatives. In September 2024, SBC Medical was listed on the Nasdaq, and in June 2025, it was selected to be included in the Russell 3000® Index, a broad-based U.S. equity market benchmark. Guided by its Group Vision, “Contributing to the well-being of people around the world through medical innovation,” SBC Medical Group Holdings Incorporated continues to provide safe, reliable, and high-quality medical services and further strengthen its international reputation for quality and trust in medical care.
For more information, please visit https://sbc-holdings.com/en
For the latest insights and information from SBC Medical, follow us on LinkedIn.
Use of Non-GAAP Financial Measures
The Company uses non-GAAP financial measures, such as EBITDA and EBITDA margin, in evaluating its operating results and for financial and operational decision-making purposes. The Company believes that these non-GAAP financial measures can help identify the underlying trends in the Company’s business. In addition, the Company believes that these non-GAAP financial measures provide useful information regarding the Company’s operating results, enhance the overall understanding of the Company’s past and future performance, and allow for better visibility into the key measures used by the Company’s management in making financial and operational decisions. Non-GAAP financial measures